Simple Summary According to the available data, colorectal cancer (CRC) is one of the most
common malignant neoplasms. Depending on the location, type of cancer or gender, it is …

Every year, cancer claims millions of lives around the globe. Unfortunately, model systems
that accurately mimic human oncology–a requirement for the development of more effective …

The human gut microbiota is increasingly recognized as a player in colorectal cancer (CRC).
While particular imbalances in the gut microbiota have been linked to colorectal adenomas …

The dimethyhydrazine (DMH) or azoxymethane (AOM) model is a well‐established, well‐
appreciated, and widely used model of experimental colon carcinogenesis. It has many …

Initial research on vitamin E and cancer has focused on α-tocopherol (αT), but recent clinical
studies on cancer-preventive effects of αT supplementation have shown disappointing …

Several scientific and clinical studies have shown an association between chronic alcohol
consumption and the occurrence of cancer in humans. The mechanism for alcohol-induced …

There is a strong demand for the identification of new biomarkers in colorectal cancer (CRC)
diagnosis. Among all liquid biopsy analysts, cell-free circulating DNA (cfDNA) is probably …

Individuals with inflammatory bowel disease (IBD), such as Crohn's disease (CD) or
ulcerative colitis (UC) are at increased risk of developing colorectal cancer (CRC) over …

Colorectal cancer (CRC) is one of the most common malignancies and has been a leading
cause of cancer-related death worldwide in recent years. N6-methyladenosine (m6A) …

A natural phenolic compound, protocatechuic acid (3, 4-dihydroxybenzoic acid), is present
in many edible and medicinal plants. Recent studies, including our animal experiments …